Beijing Tongrentang Co Ltd (600085.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE000000R69

Price
24.71 CNY
Market cap
33.89 bn CNY
P/E (2025)
28.49
P/S (2025)
1.96
Dividend yield
2.02 %
Net margin
6.89 %
Return on equity (ROE)
5.56 %
Return on assets (ROA)
3.88 %

Beijing Tongrentang Co Ltd financials

Fiscal year20242025
Revenue18.60 bn CNY17.26 bn CNY
Gross profit8.09 bn CNY7.40 bn CNY
Operating income2.80 bn CNY2.09 bn CNY
EBIT2.70 bn CNY2.15 bn CNY
Net income1.53 bn CNY1.19 bn CNY
Diluted EPS – continuing operations1.11 CNY0.87 CNY

Full history since 1994, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Beijing Tongrentang Co Ltd

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.

Beijing Tongrentang Co Ltd stock (600085.SS): P/E, revenue, dividend | finmetric